Severity Prognosis (Clinical Analysis) Equipment
1 equipment items found
-
based in FRANCE
with increased survival and better prognosis in several cancers. The boost of NK cell cytotoxic function locally in the tumor can increase the rate of cancer cell destruction and trigger an improved immune response to the tumor. CD160-TM is a novel NK cell activating receptor involved in their cytotoxic activity. Alderaan Biotechnology is developing ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you